Aricescu, A.R., McKinnell, I.W., Halfter, W., Stoker, A.W., 2002. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol. Cell. Biol. 22, 1881–1892.
Arnold, P.M., Harrop, J.S., Merli, G., Tetreault, L.G., Kwon, B.K., Casha, S., Palmieri, K., Wilson, J.R., Fehlings, M.G., Holmer, H.K., Norvell, D.C., 2017. Efficacy, safety, and timing of anticoagulant thromboprophylaxis for the prevention of venous thromboembolism in patients with acute spinal cord injury: a systematic review. Global Spine J 7, 138S–150S.
Basso, D.M., Beattie, M.S., Bresnahan, J.C., 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1–21.
Basso, D.M., Beattie, M.S., Bresnahan, J.C., 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244–256.
Bergamaschini, L., Rossi, E., Storini, C., Pizzimenti, S., Distaso, M., Perego, C., De Luigi, A., Vergani, C., De Simoni, M.G., 2004. Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer’s disease. J. Neurosci. 24, 4181–4186.
Bishop, J.R., Schuksz, M., Esko, J.D., 2007. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030–1037.
Bradbury, E.J., Moon, L.D., Popat, R.J., King, V.R., Bennett, G.S., Patel, P.N., Fawcett, J. W., McMahon, S.B., 2002. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636–640.
Coles, C.H., Shen, Y., Tenney, A.P., Siebold, C., Sutton, G.C., Lu, W., Gallagher, J.T., Jones, E.Y., Flanagan, J.G., Aricescu, A.R., 2011. Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension. Science 332, 484–488.
Cui, H., King, A.E., Jacobson, G.A., Small, D.H., 2017. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice. J. Neurosci. Res. 95, 992–999.
Doody, K.M., Stanford, S.M., Sacchetti, C., Svensson, M.N., Coles, C.H., Mitakidis, N., Kiosses, W.B., Bartok, B., Fos, C., Cory, E., Sah, R.L., Liu-Bryan, R., Boyle, D.L., Arnett, H.A., Mustelin, T., Corr, M., Esko, J.D., Tremblay, M.L., Firestein, G.S., Aricescu, A.R., Bottini, N., 2015. Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy. Sci. Transl. Med. 7, 288ra276.
Doster, S.K., Lozano, A.M., Aguayo, A.J., Willard, M.B., 1991. Expression of the growth- associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron 6, 635–647.
Floris, S., van den Born, J., Van der Pol, S.M.A., Dijkstra, C.D., de Vries, H.E., 2003. Heparan sulfate proteoglycans modulate monocyte migration across cerebral endothelium. J. Neuropathol. Exp. Neurol. 62, 780–790.
Gardner, R.T., Wang, L., Lang, B.T., Cregg, J.M., Dunbar, C.L., Woodward, W.R., Silver, J., Ripplinger, C.M., Habecker, B.A., 2015. Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias. Nat. Commun. 6, 6235.
Hasegawa, J., Iwamoto, R., Otomo, T., Nezu, A., Hamasaki, M., Yoshimori, T., 2016. Autophagosome-lysosome fusion in neurons requires INPP5E, a protein associated with Joubert syndrome. EMBO J. 35, 1853–1867.
Holmes, B.B., DeVos, S.L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M.O., Brodsky, F.M., Marasa, J., Bagchi, D.P., Kotzbauer, P.T., Miller, T.M., Papy- Garcia, D., Diamond, M.I., 2013. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl. Acad. Sci. U. S. A. 110, E3138–E3147.
Imagama, S., Sakamoto, K., Tauchi, R., Shinjo, R., Ohgomori, T., Ito, Z., Zhang, H., Nishida, Y., Asami, N., Takeshita, S., Sugiura, N., Watanabe, H., Yamashita, T., Ishiguro, N., Matsuyama, Y., Kadomatsu, K., 2011. Keratan sulfate restricts neural plasticity after spinal cord injury. J. Neurosci. 31, 17091–17102.
Itakura, E., Chiba, M., Murata, T., Matsuura, A., 2020. Heparan sulfate is a clearance receptor for aberrant extracellular proteins. J. Cell Biol. 219.
Kadomatsu, K., Sakamoto, K., 2014a. Mechanisms of axon regeneration and its inhibition: roles of sulfated glycans. Arch. Biochem. Biophys. 558, 36–41.
Kadomatsu, K., Sakamoto, K., 2014b. Sulfated glycans in network rewiring and plasticity after neuronal injuries. Neurosci. Res. 78, 50–54.
Kawai, S., Takagi, Y., Kaneko, S., Kurosawa, T., 2011. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp. Anim. 60, 481–487.
Kim, D., Adipudi, V., Shibayama, M., Giszter, S., Tessler, A., Murray, M., Simansky, K.J., 1999. Direct agonists for serotonin receptors enhance locomotor function in rats that received neural transplants after neonatal spinal transection. J. Neurosci. 19, 6213–6224.
Lang, B.T., Cregg, J.M., DePaul, M.A., Tran, A.P., Xu, K., Dyck, S.M., Madalena, K.M., Brown, B.P., Weng, Y.L., Li, S., Karimi-Abdolrezaee, S., Busch, S.A., Shen, Y., Silver, J., 2015. Modulation of the proteoglycan receptor PTPσ promotes recovery after spinal cord injury. Nature 518, 404–408.
Laporte, S., Liotier, J., Bertoletti, L., Kleber, F.X., Pineo, G.F., Chapelle, C., Moulin, N., Mismetti, P., 2011. Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients. J. Thromb. Haemost. 9, 464–472.
Lee, J.Y., Koga, H., Kawaguchi, Y., Tang, W., Wong, E., Gao, Y.S., Pandey, U.B., Kaushik, S., Tresse, E., Lu, J., Taylor, J.P., Cuervo, A.M., Yao, T.P., 2010. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J. 29, 969–980.
Leveugle, B., Ding, W., Laurence, F., Dehouck, M.P., Scanameo, A., Cecchelli, R., Fillit, H., 1998. Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide. J. Neurochem. 70, 736–744.
McKeon, R.J., Jurynec, M.J., Buck, C.R., 1999. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 19, 10778–10788.
Metz, G.A., Whishaw, I.Q., 2009. The ladder rung walking task: a scoring system and its practical application. J. Vis. Exp. 28, 1204.
Moon, L.D., Asher, R.A., Rhodes, K.E., Fawcett, J.W., 2001. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4, 465–466.
Ohtake, Y., Kong, W., Hussain, R., Horiuchi, M., Tremblay, M.L., Ganea, D., Li, S., 2017. Protein tyrosine phosphatase σ regulates autoimmune encephalomyelitis development. Brain Behav. Immun. 65, 111–124.
Pannucci, C.J., Rockwell, W.B., Ghanem, M., Fleming, K.I., Momeni, A., Agarwal, J., 2017. Inadequate enoxaparin dosing predicts 90-day venous thromboembolism risk among plastic surgery inpatients: an examination of enoxaparin pharmacodynamics. Plast. Reconstr. Surg. 139.
Rosenzweig, E.S., Salegio, E.A., Liang, J.J., Weber, J.L., Weinholtz, C.A., Brock, J.H., Moseanko, R., Hawbecker, S., Pender, R., Cruzen, C.L., Iaci, J.F., Caggiano, A.O., Blight, A.R., Haenzi, B., Huie, J.R., Havton, L.A., Nout-Lomas, Y.S., Fawcett, J.W., Ferguson, A.R., Beattie, M.S., Bresnahan, J.C., Tuszynski, M.H., 2019. Chondroitinase improves anatomical and functional outcomes after primate spinal cord injury. Nat. Neurosci. 22, 1269–1275.
Sakamoto, K., Ozaki, T., Ko, Y.C., Tsai, C.F., Gong, Y., Morozumi, M., Ishikawa, Y., Uchimura, K., Nadanaka, S., Kitagawa, H., Zulueta, M.M.L., Bandaru, A., Tamura, J. I., Hung, S.C., Kadomatsu, K., 2019. Glycan sulfation patterns define autophagy flux at axon tip via PTPRsigma-cortactin axis. Nat. Chem. Biol. 15, 699–709.
Sarrazin, S., Lamanna, W.C., Esko, J.D., 2011. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3.
Schnoor, M., Stradal, T.E., Rottner, K., 2018. Cortactin: cell functions of a multifaceted actin-binding protein. Trends Cell Biol. 28, 79–98.
Shaw, P.X., Sang, A., Wang, Y., Ho, D., Douglas, C., Dia, L., Goldberg, J.L., 2017. Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury. Exp. Eye Res. 158, 33–42.
Shen, Y., Tenney, A.P., Busch, S.A., Horn, K.P., Cuascut, F.X., Liu, K., He, Z., Silver, J., Flanagan, J.G., 2009. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 326, 592–596.
Shiu, B., Le, E., Jazini, E., Weir, T.B., Costales, T., Caffes, N., Paryavi, E., O’Hara, N., Gelb, D.E., Koh, E.Y., Ludwig, S.C., 2018. Postoperative deep vein thrombosis, pulmonary embolism, and myocardial infarction: complications after therapeutic anticoagulation in the patient with spine trauma. Spine (Phila Pa 1976) 43, E766–E772.
Silver, J., Miller, J.H., 2004. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146–156.
Tamura, J.-I., Neumann, K.W., Kurono, S., Ogawa, T., 1997. Synthetic approach towards sulfated chondroitin di-, tri- and tetrasaccharides corresponding to the repeating unit. Carbohydr. Res. 305, 43–63.
Tamura, J., Nakada, Y., Taniguchi, K., Yamane, M., 2008. Synthesis of chondroitin sulfate E octasaccharide in a repeating region involving an acetamide auxiliary. Carbohydr. Res. 343, 39–47.
Tamura, J., Tsutsumishita-Nakai, N., Nakao, Y., Kawano, M., Kato, S., Takeda, N., Nadanaka, S., Kitagawa, H., 2012. Synthesis and interaction with midkine of biotinylated chondroitin sulfate tetrasaccharides. Bioorg. Med. Chem. Lett. 22, 1371–1374.
Tanne, D., Katzav, A., Beilin, O., Grigoriadis, N.C., Blank, M., Pick, C.G., Landenberg, P. v., Shoenfeld, Y., Chapman, J., 2008. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol. Dis. 30, 56–64.
Thumbikat, P., Poonnoose, P.M., Balasubrahmaniam, P., Ravichandran, G., McClelland, M.R., 2002. A comparison of heparin/warfarin and enoxaparin thromboprophylaxis in spinal cord injury: the Sheffield experience. Spinal Cord 40, 416–420.
Tom, V.J., Steinmetz, M.P., Miller, J.H., Doller, C.M., Silver, J., 2004. Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J. Neurosci. 24, 6531–6539.
Tran, A.P., Warren, P.M., Silver, J., 2020. Regulation of autophagy by inhibitory CSPG interactions with receptor PTPσ and its impact on plasticity and regeneration after spinal cord injury. Exp. Neurol. 328, 113276.
Urban, M.W., Ghosh, B., Block, C.G., Charsar, B.A., Smith, G.M., Wright, M.C., Li, S., Lepore, A.C., 2020. Protein tyrosine phosphatase σ inhibitory peptide promotes recovery of diaphragm function and sprouting of bulbospinal respiratory axons after cervical spinal cord injury. J. Neurotrauma 37, 572–579.
Warren, P.M., Steiger, S.C., Dick, T.E., MacFarlane, P.M., Alilain, W.J., Silver, J., 2018. Rapid and robust restoration of breathing long after spinal cord injury. Nat. Commun. 9, 4843.
Xie, Y., Massa, S.M., Ensslen-Craig, S.E., Major, D.L., Yang, T., Tisi, M.A., Derevyanny, V. D., Runge, W.O., Mehta, B.P., Moore, L.A., Brady-Kalnay, S.M., Longo, F.M., 2006. Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase function. J. Biol. Chem. 281, 16482–16492